1. Introduction {#sec0005}
===============

Breast sarcomas, which develop from mesenchymal tissue, are rare and their annual incidence is approximately 4.6 cases/1,000,000 women, representing less than 1% of all breast malignancies. They can appear as primary forms (*de novo*) or secondary to chronic lymphedema or radiation therapy on the breast or chest wall, with the two forms presenting different features. The primary forms appear histologically as heterogenous subtypes and their mean age of diagnosis is around 40 years. In contrast, the secondary forms typically present later at around 45--50 years and the most common histological subtype is angiosarcoma.

Lymph node metastases are uncommon in breast sarcomas and surgery represents the only potentially curative therapy, always with an adequate resection margin.

They can share some clinical features with breast carcinomas but therapy and prognosis can differ substantially.

We present this case because of the low incidence of breast sarcomas with few cases being reported, especially of primary forms, and the clinical imagery obtained.

2. Presentation of case {#sec0010}
=======================

A 41 year old woman, who had been diagnosed previously with a fibroadenoma on the left breast, attended our hospital after having noticed an increase in its size. Her personal history did not feature other important details. The examination revealed a 7 cm retroareolar nodule, well-defined and tough. Breast ultrasound described the previously known fibroadenoma and a hypoechoic bilobulated lesion with thick margins ([Fig. 1](#fig0005){ref-type="fig"}) and the result of the citology we obtained by fine needle aspiration was connective-adipose tissue. The MRI showed a large size polinodular image, without signs of necrosis or haemorrhage, suggesting a possible Phyllodes tumor ([Fig. 2](#fig0010){ref-type="fig"}). The images revealed a low diffusion and a rapid contrast-enhancement with a posterior plateau. We decided to perform a core needle biopsy with a histological result of low-grade fusiform cells sarcoma on Phyllodes tumor. As a consequence of these results, we made a staging study on the disease extent by a thoracic and abdominal scanner without signs of disease spread, so we proceeded to surgical treatment with a mastectomy of the left breast and posterior reconstruction with prosthesis ([Fig. 3](#fig0015){ref-type="fig"}).

After two and a half years of close monitoring, she came again to our hospital because of a tough nodule over the mastectomy scar and the breast ultrasound revealed a heterogeneous epidermic nodule of 19 mm ([Fig. 4](#fig0020){ref-type="fig"}). It was resected and the histological result showed fusiform cell sarcoma. Considering the diagnosis of recurrence of the disease, surgical treatment was performed with an enlargement of tumor margins, resecting the pectoral muscle and removing the prosthesis.

3. Discussion {#sec0015}
=============

Breast sarcoma is a rare but aggressive entity. Due to its rarity, there have not been sufficient studies of its clinicopathological features and adequate treatment approach to achieve a consensus in terms of management of the disease, with published articles usually being small retrospective case reports and reviews.

In most cases, the etiology is unknown and although women who receive radiotherapy have an increased risk of presenting secondary breast sarcoma, the absolute incidence is small.

Clinically it appears as a unilateral, well-defined and large mass; it often grows faster than epithelial breast carcinoma. It can be suspected with a physical examination or through imaging tools, but core biopsy is required for diagnosis [@bib0005].

With regard to imaging, either breast ultrasound, mamography or MRI can be useful. The feature usually found in the imagery is the presence of a mass with irregular margins with or without calcifications. It appears to be frequently hypoechoic at ultrasound and T2 hyperintense at MRI [@bib0010], [@bib0015].

Lymphatic spread is uncommon in this entity, and dissemination usually occurs haematogenously and the principal organs to be metastasized are lungs, bones and liver. This is why sentinel lymph node biopsy has not been studied in these cases, as it does not seem to offer sufficient benefit to the patient or to prompt a change in clinical management. Consequently, this means that staging studies will differ from other breast tumors due to the fact that nodal status in breast sarcoma is less informative, so in these cases chest computed tomography is helpful for staging since lungs are the predominant metastatic sites.

Surgery is the standard treatment. Tumor size and adequate resection margin are the most important prognostic factors; in fact, an adequate resection margin is the most important determinant of long-term survival. Rutinary lymphadenectomy does not seem to improve outcomes [@bib0020], [@bib0025].

There is some controversy about the use of radiotherapy or chemotherapy in these patients, so there is no consensus as to the use of adjuvant therapy and it will depend mainly on the risk of tumor recurrence. Taking this into account, the use of radiotherapy seems to be recommended after positive margin resection due to the high risk of recurrence and those cases in which a R0 resection is achieved but tumors are larger than 5 cm or there is a high grade sarcoma. Prior to radiotherapy, chemotherapy is based on the Doxorubicin and Ifosfamide scheme, however there is no evidence supporting their use as response rates of breast sarcoma seem to be limited [@bib0005], [@bib0020]. A close follow-up is recommendable during the first two years because approximately 80% of recurrences appear in this period.

In the present case, the initial surgery involving mastectomy and achieving negative resection margins (R0) in a low grade tumor led us to dismiss other adjuvant treatment because of the aforementioned controversy about these therapies. However, once the diagnosis of local recurrence of the disease was confirmed, we recommended completing the surgical treatment with an enlargement of tumor margins and undergoing postoperative radiation therapy despite there being little evidence confirming the latteŕs effectiveness in improving global survival rates.

4. Conclusion {#sec0020}
=============

Breast sarcoma is a rare but aggressive entity and core biopsy is required for diagnosis. Unlike with epithelial breast carcinoma, lymphatic spread is uncommon and staging studies differ from other breast tumors due to the fact that nodal status in breast sarcoma is less informative. Consequently chest computed tomography is helpful since lungs are the predominant metastatic sites. Surgery represents the only potentially curative therapy in these cases, and tumor size and adequate resection margin are the most important prognostic factors. Some controversy still exists about the use of radiotherapy or chemotherapy, which is why currently the use of adjuvant therapy is usually limited to cases with high risk of recurrence due to positive margin resection, tumors larger than 5 cm or a high grade sarcoma. A close follow-up is recommendable during the first two years, when approximately 80% of recurrences appear.
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